Brain Iron Levels a New Marker of MS Progression? Brain Iron Levels a New Marker of MS Progression?
Monitoring levels of iron in specific areas of the brain in patients with multiple sclerosis by using novel MRI may track disease progression and assess treatment efficacy in clinical trials, new research suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 20, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Gene Variant Flags Risk for Drug-Induced Liver Injury in MS Gene Variant Flags Risk for Drug-Induced Liver Injury in MS
Researchers discovered a genetic difference that could identify people with multiple sclerosis at risk for drug-induced liver injury associated with interferon-beta therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 20, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

A molecular key for delaying the progression of Multiple Sclerosis is found
(University of the Basque Country) In the lab it was possible to improve the symptoms in the chronic phase of the disease while encouraging the repair of the nervous tissue, and the challenge now is to move the research forward in humans. This discovery is the outcome of the work by an international consortium led in the Basque Autonomous Community by the UPV/EHU and the Achucarro centre together with personnel from ciberNed and CICbiomaGUNE. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: Potential new MS drug could regenerate myelin
A study finds that blocking the M3R receptor improves myelination in mice implanted with human progenitor cells, maybe leading to clinical trials in MS. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 19, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Mother waited years to be diagnosed with MS
Fiona Elias, from Edgware, north London, says multiple sclerosis makes her 'struggle to function' and is trying to raise £50,000 for a pioneering stem cell at a hospital in Moscow. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2018 Category: Consumer Health News Source Type: news

Pain, Sleeplessness Often Precede MS: Study
WEDNESDAY, July 18, 2018 -- Pain, sleep problems and mental health disorders are common in the five years before someone is diagnosed with multiple sclerosis, a new study reveals. Knowing about these symptoms could help doctors diagnose and start... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2018 Category: General Medicine Source Type: news

Mother, 34, who woke up unable to move as a teenager waited years to be diagnosed with MS
Fiona Elias, from Edgware, north London, says multiple sclerosis makes her 'struggle to function' and is trying to raise £50,000 for a pioneering stem cell at a hospital in Moscow. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2018 Category: Consumer Health News Source Type: news

New MRI Test May Predict Severity of MS
Researchers hope a new MRI test that tracks iron levels in the brain will help predict how fast multiple sclerosis progresses and how severe it could be. (Source: WebMD Health)
Source: WebMD Health - July 17, 2018 Category: Consumer Health News Source Type: news

MRI links iron in the brain to multiple sclerosis
Lower levels of iron in the thalamus as seen on MRI scans of people with multiple...Read more on AuntMinnie.comRelated Reading: MRI shows potentially better indicator for MS progression Do ED MRI scans reduce hospital stays for MS patients? SIR: MRI debunks venoplasty for treating MS Timely MRI finds more brain bleeds in military TBI patients MRI protocol links gray-matter changes to MS severity (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 17, 2018 Category: Radiology Source Type: news

Medical News Today: MS: Iron levels in brain 'predict disability'
A new type of MRI that accurately monitors irons levels in different brain areas could help identify MS patients at higher risk of physical disability. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 17, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

New MRI Test May Predict Severity of MS
TUESDAY, July 17, 2018 -- People with multiple sclerosis (MS) often live with uncertainty because it's hard to predict how quickly the disease will progress and how disabling it might become. But researchers hope a new MRI test that tracks iron... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 17, 2018 Category: General Medicine Source Type: news

Vitamin D No Panacea for Brain Diseases
MONDAY, July 16, 2018 -- Vitamin D does little to defend your brain against multiple sclerosis, Parkinson's disease or Alzheimer's disease, a new review shows. The finding is based on an analysis of more than 70 studies. " Our work counters an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 16, 2018 Category: General Medicine Source Type: news

Grey Matter Atrophy for Staging Neurodegeneration in MS Grey Matter Atrophy for Staging Neurodegeneration in MS
A new study proposes a novel look at the process of neurodegeneration in multiple sclerosis, positing that it can be staged by grey matter atrophy progression over time.Brain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 16, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

A constellation of symptoms presages first definitive signs of multiple sclerosis
(University of British Columbia) Canadian researchers document the health problems that precede a diagnosis of multiple sclerosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 16, 2018 Category: International Medicine & Public Health Source Type: news

Medline buys Canadian stroke rehab device maker NeuroGym
Medline has acquired physical therapy and rehabilitation equipment maker NeuroGym Technologies of Ottawa. NeuroGym’s equipment is designed for people who have had a stroke or other traumatic brain injury, spinal cord injury, chronic neurological conditions such as multiple sclerosis, balance issues and/or the need for fall prevention therapy. The equipment requires the patient to initiate movement, which the company says can help rewire the brain and speed recovery. It includes a sit-to-stand trainer, bungee mobility trainer to re-teach walking and improve balance, a pendulum stepper for lower extremit...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Source Type: news

Research: Vitamin D doesn't protect patients from brain-related disorders
Vitamin D unlikely protectd people from several brain-related disorders, including multiple sclerosis, Parkinson's disease, Alzheimer's disease and dementia. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 10, 2018 Category: Consumer Health News Source Type: news

Hope for multiple sclerosis treatment as scientists say limiting calories could reduce symptoms
Researchers at Washington University in St Louis are starting a trial to examine whether reducing people's calorie intake could help to relieve their multiple sclerosis symptoms. (Source: the Mail online | Health)
Source: the Mail online | Health - July 10, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Intermittent fasting may benefit people with MS
Multiple sclerosis is a neurological condition with no known cure, so appropriate symptom management is crucial. Could intermittent fasting help? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 10, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Fear of falling, not falls, impacts leisure-time physical activity in people with multiple sclerosis - Kalron A, Aloni R, Givon U, Menascu S.
BACKGROUND: There is a consensus that physical activity is imperative for people with MS (PwMS). However, regardless of the benefits, many PwMS do not participate in any meaningful physical activity. AIM: To examine the relationship between leisure... (Source: SafetyLit)
Source: SafetyLit - July 10, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Vitamin D no defense against dementia
(University of Adelaide) New research from South Australian scientists has shown that vitamin D (also commonly known as the sunshine vitamin) is unlikely to protect individuals from multiple sclerosis, Parkinson's disease, Alzheimer's disease or other brain-related disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2018 Category: International Medicine & Public Health Source Type: news

Can fasting improve MS symptoms?
(Washington University School of Medicine) People with multiple sclerosis (MS) can find an abundance of conflicting advice suggesting that special diets will ease their symptoms. But the evidence is scanty. Laura Piccio, M.D., an associate professor of neurology at Washington University School of Medicine in St. Louis has launched a trial to evaluate whether drastically cutting calories twice a week can change the body's immune environment and the gut microbiome, and potentially change the course of the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2018 Category: International Medicine & Public Health Source Type: news

Organic Solvents & #43; Genetics May Increase Risk of Multiple Sclerosis
FRIDAY, July 6, 2018 -- The combination of genetics and exposure to organic solvents in paints and varnishes increases the risk of multiple sclerosis (MS), according to a study published online July 3 in Neurology. Anna Karin Hedstrom, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 6, 2018 Category: Pharmaceuticals Source Type: news

Common Solvents Strongly Tied to MS Risk Common Solvents Strongly Tied to MS Risk
There is a strong association between exposure to organic solvents and multiple sclerosis risk, especially among those who smoke and carry a genetic risk.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Balance exercise facilitates everyday life for people with multiple sclerosis: a qualitative study - Carling A, Nilsag ård Y, Forsberg A.
OBJECTIVES: The aim of this qualitative study was to describe the experience and perceived effects on everyday life for people with multiple sclerosis after participating in a balance exercise programme focusing on core stability, dual tasking, and sensory... (Source: SafetyLit)
Source: SafetyLit - July 5, 2018 Category: International Medicine & Public Health Tags: Falls Source Type: news

Paint and varnish may increase people's risk of multiple sclerosis
Researchers from the Karolinska Institute, Stockholm, found that people who carry MS genes are nearly seven times more likely to develop it if they are exposed to such solvents. (Source: the Mail online | Health)
Source: the Mail online | Health - July 4, 2018 Category: Consumer Health News Source Type: news

Medical News Today: MS: Solvent exposure raises risk by 50 percent
A new study shows that a combination of smoking, genetic predisposition, and exposure to solvents increases the risk of developing MS by 30-fold. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 4, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Chemicals in paint and varnish may increase people's risk of developing multiple sclerosis
Researchers from the Karolinska Institute, Stockholm, found that people who carry MS genes are nearly seven times more likely to develop it if they are exposed to such solvents. (Source: the Mail online | Health)
Source: the Mail online | Health - July 3, 2018 Category: Consumer Health News Source Type: news

Paints, Solvents Tied to Big Rise in MS Risk for Some Smokers
TUESDAY, July 3, 2018 -- A triple whammy of genetics, smoking, and exposure to paints and solvents at work puts a person at extremely high risk of developing multiple sclerosis, Swedish researchers report. On its own, any one factor elevates the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2018 Category: General Medicine Source Type: news

Dynamics of Brain Volume Loss Vary With MS Progression
TUESDAY, July 3, 2018 -- Brain volume loss (BVL) has nonlinear dynamics and limited reproducibility as a marker of therapeutic response in multiple sclerosis (MS), according to a study published online July 2 in JAMA Neurology. Mag í Andorra, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 3, 2018 Category: Pharmaceuticals Source Type: news

ReWalk Robotics amends soft exoskeleton research, licensing deal with Harvard
UPDATE: Corrected to reflect that ReWalk Robotics was amending an earlier deal. ReWalk Robotics (NSDQ:RWLK) has inked a set of amendments to its collaborative research and exclusive licensing agreement with Harvard Collage related to the development of its soft-suit exoskeleton, according to a recently posted SEC filing. Through the original collaborative deal, both groups will join to aid in the development of soft-suit exoskeleton technologies designed to treat lower limb disabilities, the Marlborough, Mass.-based company said. The suit is intended to treat stroke, multiple sclerosis, mobility limitations for the el...
Source: Mass Device - July 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Robotics ReWalk Robotics Source Type: news

Neurologic-focused digital therapeutics group MedRhythms raises $5m
Early stage medtech company MedRhythms said today it raised $5.3 million in a Series A round of financing to help support its platform intended to use neurologic interventions to measure and improve walking. The Portland, Maine-based company said it initially intended to raise $4 million, but found “substantial interest” and ended up netting extra funds. MedRhythms added that it has already closed $5 million from the round. Funds will support continued development and a potential launch of MedRhythm’s digital therapeutics platform intended to aid individuals with neurologic injuries and diseases and impro...
Source: Mass Device - June 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Neurological medrhythms Source Type: news

Egress efficacy of persons with multiple sclerosis during simulated evacuations - Kesler RM, Klieger AE, Boes MK, Hsiao-Wecksler ET, Klaren RE, Learmonth Y, Motl RW, Horn GP.
Expedited evacuation of commercial and residential structures in the event of an emergency may be more difficult for persons with physical movement disorders. There is a need to better characterize the impact of such disorders and provide movement data to ... (Source: SafetyLit)
Source: SafetyLit - June 28, 2018 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Latest advances in cognitive rehabilitation for cognitive effects of Multiple sclerosis
(Kessler Foundation) " This text details the scope of cognitive issues encountered in MS, and focuses on guiding professionals to consider the latest scientific knowledge in their protocols for cognitive rehabilitation, including neuroimaging, exercise, medication, and mobile technologies, " said Dr DeLuca. " By reducing the burden on individuals and caregivers, we can begin to address the broader social impact of MS. " (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 27, 2018 Category: International Medicine & Public Health Source Type: news

New EAN Guideline on Palliative Care in MS New EAN Guideline on Palliative Care in MS
A new palliative care guideline for patients with multiple sclerosis, many of whom suffer great pain, recommends a multidisciplinary approach and reflects new emphasis in neurology on palliative care.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

UCLA global health program aims to boost neurological care in South Africa
When it came to getting the best treatment for his parents ’ neurologic illnesses, Sam Miller and his family experienced frustration finding the right doctors in their home country of South Africa.Miller ’s mother, Brenda, developed multiple sclerosis in her late 20s, and his father, Winston, was diagnosed with Parkinson’s disease in his 60s.Over the four decades of his mother ’s illness before her death in 2008, the increasingly acute shortage of neurologists in South Africa made the top specialists there much sought-after and overworked. They had little time to talk through treatment options, much...
Source: UCLA Newsroom: Health Sciences - June 26, 2018 Category: Universities & Medical Training Source Type: news

New nuclear medicine technique could help tackle brain disease
(Society of Nuclear Medicine and Molecular Imaging) A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: What causes internal vibrations?
Internal vibrations, or internal tremors, are shaking sensations felt inside the body, and a person will often exhibit no visible movement. These tremors are associated with conditions such as Parkinson's disease and multiple sclerosis. In this article, learn about the causes and treatments of internal vibrations. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 22, 2018 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

What causes internal vibrations?
Internal vibrations, or internal tremors, are shaking sensations felt inside the body, and a person will often exhibit no visible movement. These tremors are associated with conditions such as Parkinson's disease and multiple sclerosis. In this article, learn about the causes and treatments of internal vibrations. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 22, 2018 Category: Neurology Tags: Neurology / Neuroscience Source Type: news

Medical News Today: What does it mean if you have shaky hands?
Shaky hands can interfere with everyday activities, and the tremors vary in severity. Neurological conditions, movement disorders, and issues such as anxiety or withdrawal may be responsible for the tremors, and a wide range of treatments are available. Learn more about shaky hands and types of tremor here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 20, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

What does it mean if you have shaky hands?
Shaky hands can interfere with everyday activities, and the tremors vary in severity. Neurological conditions, movement disorders, and issues such as anxiety or withdrawal may be responsible for the tremors, and a wide range of treatments are available. Learn more about shaky hands and types of tremor here. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 20, 2018 Category: Neurology Tags: Multiple Sclerosis Source Type: news

Medical News Today: Uses and risks of mitoxantine (Novantrone)
Mitoxantrone is used to treat some types of multiple sclerosis (MS) and some types of cancer. It is given as an intravenous infusion in a clinical setting. Some serious side effects are possible, and it is important to discuss the risks and any existing health conditions with the doctor. Novantrone is a trade name. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 20, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Mechanism controlling multiple sclerosis risk identified
(Karolinska Institutet) While the DNA sequence remains the same throughout a person's life, the expression of the encoded genes may change with time and contribute to disease development in genetically predisposed individuals. Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS. The study is published in Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Rheumatoid Arthritis Phase 4 Clinical Trial Data Recently Presented at the Annual European Congress of Rheumatology (EULAR 2018) Multiple Sclerosis Relapse Observational Registry Data Recently Presented at the 2018 Annual Meeting of the Consortium of Mu... Biopharmaceuticals Mallinckrodt, H.P. Acthar Gel, Rheumatoid Arthritis, Multiple Sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Suicidal ideation, anxiety, and depression in patients with multiple sclerosis - Tauil CB, Grippe TC, Dias RM, Dias-Carneiro RPC, Carneiro NM, Aguilar ACR, Silva FMD, Bezerra F, Almeida LK, Massarente VL, Giovannelli EC, Tilbery CP, Brand ão CO, Santos LMB, Santos-Neto LD.
INTRODUCTION: Psychiatric disorders frequently occur in patients with multiple sclerosis (MS); however, limited reports are available on these comorbidities. We aimed to investigate the relationships among MS, anxiety, depression, and suicidal ideation. ... (Source: SafetyLit)
Source: SafetyLit - June 18, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Science Saturday: Autoimmune disorders unmasked
Editor?s note: Recently Mayo Clinic launched a first-in-the-U.S. clinical test to help patients get the right diagnosis faster when it comes to diseases like multiple sclerosis (MS). This is the story of how tests like that are developed at Mayo. Diseases of the human body evolve and change, but their effect on patients is fixed. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 16, 2018 Category: Databases & Libraries Source Type: news

Shrinking MS Lesions a New Biomarker for Disease Progression? Shrinking MS Lesions a New Biomarker for Disease Progression?
Investigators propose a new biomarker for multiple sclerosis progression based on lesion volume atrophy over time.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Medical News Today: MS: New findings may 'prevent future loss of brain cells'
Scientists have now identified a unique cell death mechanism behind the destruction of nerve insulation in MS, and an anti-inflammatory that blocks it. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 14, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Roche announces new OCREVUS (ocrelizumab) data on long-term disability benefits in primary progressive multiple sclerosis and initiation of two global studies in progressive multiple sclerosis
Roche today announced that new OCREVUS (ocrelizumab) data will be presented at the 4th Congress of the European Academy of Neurology (EAN) from 16 June to 19 June in Lisbon, Portugal. (Source: Roche Media News)
Source: Roche Media News - June 14, 2018 Category: Pharmaceuticals Source Type: news

Roche announces new OCREVUS (ocrelizumab) data on long-term disability benefits in primary progressive multiple sclerosis and initiation of two global studies in progressive multiple sclerosis
Roche today announced that new OCREVUS (ocrelizumab) data will be presented at the 4th Congress of the European Academy of Neurology (EAN) from 16 June to 19 June in Lisbon, Portugal. (Source: Roche Investor Update)
Source: Roche Investor Update - June 14, 2018 Category: Pharmaceuticals Source Type: news